In patients with HCV-related cirrhosis the annual risk of hepatocellular carcinoma (HCC) is 2–4%.1 However, with the advent of highly effective and well tolerated direct-acting antivirals...
Calvaruso V., Bruix J. (2020). Towards personalized screening for hepatocellular carcinoma: Still not there. JOURNAL OF HEPATOLOGY, 73(6), 1319-1321 [10.1016/j.jhep.2020.06.032].
Towards personalized screening for hepatocellular carcinoma: Still not there
Calvaruso V.
;
2020-01-01
Abstract
In patients with HCV-related cirrhosis the annual risk of hepatocellular carcinoma (HCC) is 2–4%.1 However, with the advent of highly effective and well tolerated direct-acting antivirals...
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Towards personalized screening for hepatocellular carcinoma- still not there.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
360.64 kB
Formato
Adobe PDF
|
360.64 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
